Paper41220006
Protein acylation in inflammatory diseases: from mechanisms to therapeutic strategies.
Ding J and 4 others. Cell Commun Signal, 2025. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Protein acylation in inflammatory diseases: from mechanisms to therapeutic strategies. Papers, record 41220006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41220006
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Inflammation | Major topic |
| Protein Processing, Post-Translational | Major topic |
| Proteins | Major topic |
| Humans | |
| Acylation | |
| Animals |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82101022 | National Natural Science Foundation of China | PubMed | ||
| 82170963, 82370967 | National Natural Science Foundation of China | PubMed | ||
| 2023YFC2506300 | National Key Research and Development Program of China | PubMed |
Source PubMed
References220
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37244925 | Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37244925 | PubMed |
| 2 | 36936452 | Protective effect of HDACIs in improves survival and organ injury after CLP-induced sepsis. | Surg Open Sci | 2023 | https://conductscience.org/library/papers/36936452 | PubMed |
| 3 | 34789273 | Artificial exosomes mediated spatiotemporal-resolved and targeted delivery of epigenetic inhibitors. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/34789273 | PubMed |
| 4 | 36631984 | Longevity of teeth in patients susceptible to periodontitis: Clinical outcomes and risk factors associated with tooth loss after active therapy and 30 years of supportive periodontal care. | J Clin Periodontol | 2023 | https://conductscience.org/library/papers/36631984 | PubMed |
| 5 | 39113793 | Methyl-CpG-binding 2 K271 lactylation-mediated M2 macrophage polarization inhibits atherosclerosis. | Theranostics | 2024 | https://conductscience.org/library/papers/39113793 | PubMed |
| 6 | 36439872 | Lactylation of PKM2 Suppresses Inflammatory Metabolic Adaptation in Pro-inflammatory Macrophages. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/36439872 | PubMed |
| 7 | 38244675 | SIRT1-dependent PGC-1α deacetylation by SRT1720 rescues progression of atherosclerosis by enhancing mitochondrial function. | Biochim Biophys Acta Mol Cell Biol Lipids | 2024 | https://conductscience.org/library/papers/38244675 | PubMed |
| 8 | 32770227 | Histone deacetylase 4 inhibits NF-κB activation by facilitating IκBα sumoylation. | J Mol Cell Biol | 2020 | https://conductscience.org/library/papers/32770227 | PubMed |
| 9 | 34335587 | p53 Deacetylation Alleviates Sepsis-Induced Acute Kidney Injury by Promoting Autophagy. | Front Immunol | 2021 | https://conductscience.org/library/papers/34335587 | PubMed |
| 10 | 39379937 | Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39379937 | PubMed |
| 11 | 27078884 | Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice. | Toxicol Appl Pharmacol | 2016 | https://conductscience.org/library/papers/27078884 | PubMed |
| 12 | 36586411 | Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy. | Mol Cell | 2023 | https://conductscience.org/library/papers/36586411 | PubMed |
| 13 | 32011025 | Periodontitis and cardiovascular diseases: Consensus report. | J Clin Periodontol | 2020 | https://conductscience.org/library/papers/32011025 | PubMed |
| 14 | 37598147 | Targeting macrophage M1 polarization suppression through PCAF inhibition alleviates autoimmune arthritis via synergistic NF-κB and H3K9Ac blockade. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/37598147 | PubMed |
| 15 | 21081649 | SIRT2 regulates NF-κB dependent gene expression through deacetylation of p65 Lys310. | J Cell Sci | 2010 | https://conductscience.org/library/papers/21081649 | PubMed |
| 16 | 36702861 | The HDAC inhibitor zabadinostat is a systemic regulator of adaptive immunity. | Commun Biol | 2023 | https://conductscience.org/library/papers/36702861 | PubMed |
| 17 | 36717759 | Salivary histone deacetylase in periodontal disease: A cross-sectional pilot study. | J Periodontal Res | 2023 | https://conductscience.org/library/papers/36717759 | PubMed |
| 18 | 33045661 | Current development of CBP/p300 inhibitors in the last decade. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33045661 | PubMed |
| 19 | 16369556 | Dampening inflammation. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16369556 | PubMed |
| 20 | 37736721 | Sirt6 enhances macrophage lipophagy and improves lipid metabolism disorder by regulating the Wnt1/β-catenin pathway in atherosclerosis. | Lipids Health Dis | 2023 | https://conductscience.org/library/papers/37736721 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42839118 | Protein acylation and bone metabolism: bidirectional crosstalk linking metabolic reprogramming to skeletal homeostasis. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42839118 | PubMed |
| 42780579 | Research progress on protein lactylation in female reproductive disease: molecular mechanisms, functions, and therapeutic implications. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42780579 | PubMed |
| 42699205 | Metabolite-driven protein modifications in immune signaling: from established principles to emerging pyruvylation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42699205 | PubMed |
| 42166030 | Epigenetic memory in periodontal healing: mechanisms, evidence, and emerging therapeutic perspectives. | Odontology | 2026 | https://conductscience.org/library/papers/42166030 | PubMed |
| 42131326 | Metabolic-epigenetic rewiring in rheumatoid arthritis: from pathogenic memory to precision restoration. | Front Immunol | 2026 | https://conductscience.org/library/papers/42131326 | PubMed |
| 41677759 | Comprehensive Proteomics and β-Hydroxybutyrylation Profiling in Starvation-Induced Gastrocnemius Muscle Remodeling. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/41677759 | PubMed |
| 41630001 | Processes and therapeutic perspectives of acylation modifications of lysine and cysteine in tumors. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41630001 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41220006
GET https://conductscience.org/api/papers/v1/41220006/references?page=2